#begin document (en_1114.txt); part 000
en_1114.txt	0	0	Curing	NNP	(TOP(NP*	-	-	-	-	*	(0
en_1114.txt	0	1	Hereditary	NNP	*	-	-	-	-	*	-
en_1114.txt	0	2	Breast	NNP	*	-	-	-	-	*	-
en_1114.txt	0	3	Cancer	NNP	*))	-	-	-	-	*	0)

en_1114.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1114.txt	0	1	developed	JJ	(NP*	-	-	-	-	*	(1
en_1114.txt	0	2	countries	NNS	*))	-	-	-	-	*	1)
en_1114.txt	0	3	,	,	*	-	-	-	-	*	-
en_1114.txt	0	4	breast	NN	(S(NP*	-	-	-	-	*	-
en_1114.txt	0	5	cancer	NN	*)	-	-	-	-	*	-
en_1114.txt	0	6	affects	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	about	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	one	CD	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	10	ten	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	11	women	NNS	*))))))	-	-	-	-	*	-
en_1114.txt	0	12	,	,	*	-	-	-	-	*	-
en_1114.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	14	in	IN	(S(PP*	-	-	-	-	*	-
en_1114.txt	0	15	many	JJ	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	17	these	DT	(NP*	-	-	-	-	*	(1
en_1114.txt	0	18	countries	NNS	*))))	-	-	-	-	*	1)
en_1114.txt	0	19	the	DT	(NP*	-	-	-	-	*	(0
en_1114.txt	0	20	disease	NN	*)	-	-	-	-	*	0)
en_1114.txt	0	21	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	22	on	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	23	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	24	increase	NN	*))))	-	-	-	-	*	-
en_1114.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	whatever	WDT	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	3	the	DT	(FRAG(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	4	reason	NN	*)	-	-	-	-	*	-
en_1114.txt	0	5	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1114.txt	0	6	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	7	reasons	NNS	(NP*)	-	-	-	-	*	-
en_1114.txt	0	8	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1114.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	11	rise	NN	*)	-	-	-	-	*	-
en_1114.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	13	their	PRP$	(NP*	-	-	-	-	*	(1)
en_1114.txt	0	14	occurrence	NN	*)))))))	-	-	-	-	*	-
en_1114.txt	0	15	,	,	*	-	-	-	-	*	-
en_1114.txt	0	16	we	PRP	(NP*)	-	-	-	-	*	-
en_1114.txt	0	17	also	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	18	know	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	19	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	20	between	IN	(S(NP(NP(QP*	-	-	-	-	*	-
en_1114.txt	0	21	5	CD	*	-	-	-	-	*	-
en_1114.txt	0	22	%	NN	*	-	-	-	-	*	-
en_1114.txt	0	23	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	24	10	CD	*	-	-	-	-	*	-
en_1114.txt	0	25	%	NN	*))	-	-	-	-	*	-
en_1114.txt	0	26	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	27	breast	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	28	cancers	NNS	*)))	-	-	-	-	*	-
en_1114.txt	0	29	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	30	due	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	31	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	32	an	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	33	inherited	VBN	*	-	-	-	-	*	-
en_1114.txt	0	34	defect	NN	*)	-	-	-	-	*	-
en_1114.txt	0	35	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1114.txt	0	36	affects	VBZ	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	37	the	DT	(NP*	-	-	-	-	*	(2
en_1114.txt	0	38	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	39	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	40	BRCA2	NN	*	-	-	-	-	*	-
en_1114.txt	0	41	genes	NNS	*)))))))))))	-	-	-	-	*	2)
en_1114.txt	0	42	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Women	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	1	carrying	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	a	DT	(NP*	-	-	-	-	*	(3
en_1114.txt	0	3	mutated	VBN	*	-	-	-	-	*	-
en_1114.txt	0	4	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	5	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	6	BRCA2	NNP	*	-	-	-	-	*	-
en_1114.txt	0	7	gene	NN	*)))	-	-	-	-	*	3)
en_1114.txt	0	8	have	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	roughly	RB	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	10	an	DT	*	-	-	-	-	*	-
en_1114.txt	0	11	80	CD	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	12	%	NN	*)	-	-	-	-	*	-
en_1114.txt	0	13	risk	NN	*)	-	-	-	-	*	-
en_1114.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	15	developing	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	16	breast	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	17	cancer	NN	*))))))	-	-	-	-	*	-
en_1114.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	1	mutation	NN	*)	-	-	-	-	*	-
en_1114.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	3	these	DT	(NP*	-	-	-	-	*	(2
en_1114.txt	0	4	genes	NNS	*)))	-	-	-	-	*	2)
en_1114.txt	0	5	also	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	6	leads	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	an	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	9	increased	JJ	*	-	-	-	-	*	-
en_1114.txt	0	10	risk	NN	*)	-	-	-	-	*	-
en_1114.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	12	developing	VBG	(NP*	-	-	-	-	*	-
en_1114.txt	0	13	ovarian	NN	*	-	-	-	-	*	-
en_1114.txt	0	14	tumors	NNS	*)))))	-	-	-	-	*	-
en_1114.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	When	WRB	(TOP(S(SBAR(WHADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	the	DT	(S(NP*	-	-	-	-	*	(2
en_1114.txt	0	2	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	3	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	4	BRCA2	NNP	*	-	-	-	-	*	-
en_1114.txt	0	5	genes	NNS	*)	-	-	-	-	*	2)
en_1114.txt	0	6	were	VBD	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	discovered	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	more	JJR	(ADVP(NP(QP*	-	-	-	-	*	-
en_1114.txt	0	9	than	IN	*	-	-	-	-	*	-
en_1114.txt	0	10	a	DT	*)	-	-	-	-	*	-
en_1114.txt	0	11	decade	NN	*)	-	-	-	-	*	-
en_1114.txt	0	12	ago	RB	*)))))	-	-	-	-	*	-
en_1114.txt	0	13	,	,	*	-	-	-	-	*	-
en_1114.txt	0	14	there	EX	(NP*)	-	-	-	-	*	-
en_1114.txt	0	15	were	VBD	(VP*	-	-	-	-	*	-
en_1114.txt	0	16	high	JJ	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	17	hopes	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	18	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	19	novel	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	20	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	21	targeted	JJ	*	-	-	-	-	*	-
en_1114.txt	0	22	therapies	NNS	*))))	-	-	-	-	*	-
en_1114.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Disappointingly	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	no	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	3	new	JJ	*	-	-	-	-	*	-
en_1114.txt	0	4	treatments	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	5	have	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	yet	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	7	arisen	VBN	(VP*))	-	-	-	-	*	-
en_1114.txt	0	8	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	As	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1114.txt	0	1	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	2	result	NN	*))	-	-	-	-	*	-
en_1114.txt	0	3	,	,	*	-	-	-	-	*	-
en_1114.txt	0	4	many	JJ	(NP(NP*	-	-	-	-	*	(4
en_1114.txt	0	5	women	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	6	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	7	a	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	8	high	JJ	*	-	-	-	-	*	-
en_1114.txt	0	9	level	NN	*)	-	-	-	-	*	-
en_1114.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	11	mutated	VBN	(NP*	-	-	-	-	*	-
en_1114.txt	0	12	BRCA1	NNS	*	-	-	-	-	*	-
en_1114.txt	0	13	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	14	BRCA2	NN	*	-	-	-	-	*	-
en_1114.txt	0	15	genes	NNS	*)))))	-	-	-	-	*	4)
en_1114.txt	0	16	face	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	17	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	18	tragic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	19	choice	NN	*)	-	-	-	-	*	-
en_1114.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	21	having	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	22	their	PRP$	(S(NP*	-	-	-	-	*	(4)
en_1114.txt	0	23	breasts	NNS	*	-	-	-	-	*	-
en_1114.txt	0	24	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	25	ovaries	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	26	surgically	RB	(VP(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	27	removed	VBN	*	-	-	-	-	*	-
en_1114.txt	0	28	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	29	pre-empt	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	30	cancer	NN	(NP*)))))))))))	-	-	-	-	*	-
en_1114.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Recently	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	my	PRP$	(NP(NP*	-	-	-	-	*	(4
en_1114.txt	0	3	research	NN	*	-	-	-	-	*	-
en_1114.txt	0	4	group	NN	*)	-	-	-	-	*	4)
en_1114.txt	0	5	,	,	*	-	-	-	-	*	-
en_1114.txt	0	6	along	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	7	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	researchers	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	10	London	NNP	(NP*)))))	-	-	-	-	*	-
en_1114.txt	0	11	,	,	*)	-	-	-	-	*	-
en_1114.txt	0	12	provided	VBD	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	some	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	14	real	JJ	*	-	-	-	-	*	-
en_1114.txt	0	15	hope	NN	*)	-	-	-	-	*	-
en_1114.txt	0	16	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	17	carriers	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	19	mutated	VBN	(NP*	-	-	-	-	*	-
en_1114.txt	0	20	BRCA1	NNS	*	-	-	-	-	*	-
en_1114.txt	0	21	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	22	BRCA2	NN	*	-	-	-	-	*	-
en_1114.txt	0	23	genes	NNS	*)))))	-	-	-	-	*	-
en_1114.txt	0	24	.	.	*	-	-	-	-	*	-
en_1114.txt	0	25	Both	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	26	research	NN	*	-	-	-	-	*	-
en_1114.txt	0	27	teams	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	28	describe	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	29	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1114.txt	0	30	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	31	use	NN	*)	-	-	-	-	*	-
en_1114.txt	0	32	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	33	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	34	chemical	NN	*	-	-	-	-	*	-
en_1114.txt	0	35	inhibitor	NN	*)))	-	-	-	-	*	-
en_1114.txt	0	36	can	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	37	kill	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	38	tumor	NN	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	39	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	40	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1114.txt	0	41	have	VBP	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	42	either	CC	(NP*	-	-	-	-	*	-
en_1114.txt	0	43	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	44	BRCA1	NN	*)	-	-	-	-	*	-
en_1114.txt	0	45	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	46	BRCA2	JJ	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	47	gene	NN	*	-	-	-	-	*	-
en_1114.txt	0	48	defect	NN	*)	-	-	-	-	*	-
en_1114.txt	0	49	causing	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	50	hereditary	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	51	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	52	cancer	NN	*)))))))))))))	-	-	-	-	*	-
en_1114.txt	0	53	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	This	DT	(TOP(S(NP*	-	-	-	-	*	(5
en_1114.txt	0	1	new	JJ	*	-	-	-	-	*	-
en_1114.txt	0	2	treatment	NN	*)	-	-	-	-	*	5)
en_1114.txt	0	3	targets	VBZ	(VP(VP*	-	-	-	-	*	-
en_1114.txt	0	4	only	RB	(NP*	-	-	-	-	*	-
en_1114.txt	0	5	the	DT	*	-	-	-	-	*	-
en_1114.txt	0	6	tumor	NN	*	-	-	-	-	*	-
en_1114.txt	0	7	cells	NNS	*))	-	-	-	-	*	-
en_1114.txt	0	8	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	9	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	10	unlikely	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	11	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	12	affect	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	other	JJ	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	14	healthy	JJ	*	-	-	-	-	*	-
en_1114.txt	0	15	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	17	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	18	body	NN	*)))))))))	-	-	-	-	*	-
en_1114.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1114.txt	0	1	discovery	NN	*)	-	-	-	-	*	-
en_1114.txt	0	2	could	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	also	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	4	work	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	6	prevent	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	hereditary	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	8	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	9	cancer	NN	*	-	-	-	-	*	-
en_1114.txt	0	10	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	11	from	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	12	growing	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	13	into	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	14	tumors	NNS	(NP*))))))))))	-	-	-	-	*	-
en_1114.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	1	chemical	NN	*	-	-	-	-	*	-
en_1114.txt	0	2	inhibitors	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	3	used	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	5	this	DT	(NP*	-	-	-	-	*	(5
en_1114.txt	0	6	treatment	NN	*))))	-	-	-	-	*	5)
en_1114.txt	0	7	target	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	9	enzyme	JJ	*	-	-	-	-	*	-
en_1114.txt	0	10	polymerase	NN	*)	-	-	-	-	*	-
en_1114.txt	0	11	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1114.txt	0	12	PARP1	NNP	(NP*)	-	-	-	-	*	-
en_1114.txt	0	13	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1114.txt	0	14	,	,	*	-	-	-	-	*	-
en_1114.txt	0	15	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1114.txt	0	16	is	VBZ	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	17	normally	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	18	involved	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	19	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	20	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	21	repair	NN	*)	-	-	-	-	*	-
en_1114.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	23	DNA	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	24	single-strand	NN	*	-	-	-	-	*	-
en_1114.txt	0	25	breaks	NNS	*)))))))))	-	-	-	-	*	-
en_1114.txt	0	26	–	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	27	a	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	28	common	JJ	*	-	-	-	-	*	-
en_1114.txt	0	29	form	NN	*)	-	-	-	-	*	-
en_1114.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	31	spontaneous	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	32	DNA	NN	*	-	-	-	-	*	-
en_1114.txt	0	33	lesions	NNS	*))))))	-	-	-	-	*	-
en_1114.txt	0	34	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Chemical	NN	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	1	inhibition	NN	*)	-	-	-	-	*	-
en_1114.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	3	the	DT	(NP*	-	-	-	-	*	(6
en_1114.txt	0	4	PARP1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	5	protein	NN	*)))	-	-	-	-	*	6)
en_1114.txt	0	6	results	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	reduced	VBN	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	9	occurrence	NN	*)	-	-	-	-	*	-
en_1114.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	11	these	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	12	single-strand	JJ	*	-	-	-	-	*	-
en_1114.txt	0	13	break	NN	*	-	-	-	-	*	-
en_1114.txt	0	14	repairs	NNS	*)))))	-	-	-	-	*	-
en_1114.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Unrepaired	JJ	(TOP(S(NP*	-	-	-	-	*	(7
en_1114.txt	0	1	single-strand	NN	*	-	-	-	-	*	-
en_1114.txt	0	2	breaks	NNS	*)	-	-	-	-	*	7)
en_1114.txt	0	3	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	not	RB	*	-	-	-	-	*	-
en_1114.txt	0	5	very	RB	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	6	toxic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	7	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	cells	NNS	(NP*))))	-	-	-	-	*	-
en_1114.txt	0	9	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	However	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	these	DT	(NP*	-	-	-	-	*	(7
en_1114.txt	0	3	breaks	NNS	*)	-	-	-	-	*	7)
en_1114.txt	0	4	disrupt	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	5	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	6	damage	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	(8
en_1114.txt	0	8	DNA	NN	*)	-	-	-	-	*	-
en_1114.txt	0	9	when	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1114.txt	0	10	they	PRP	(S(NP*)	-	-	-	-	*	(7)
en_1114.txt	0	11	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	12	copied	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	as	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	14	DNA	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	15	replicates	NNS	*)))))))))	-	-	-	-	*	8)
en_1114.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	1	damage	NN	*)	-	-	-	-	*	-
en_1114.txt	0	2	arising	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	when	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1114.txt	0	4	copying	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	5	the	DT	(NP*	-	-	-	-	*	(8
en_1114.txt	0	6	DNA	NN	*))))))	-	-	-	-	*	8)
en_1114.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	repaired	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	10	recombination	NN	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	11	,	,	*	-	-	-	-	*	-
en_1114.txt	0	12	involving	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	14	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	16	BRCA2	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	17	proteins	NNS	*)))))))	-	-	-	-	*	-
en_1114.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1114.txt	0	1	cells	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	2	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	3	mutated	VBN	(NP*	-	-	-	-	*	-
en_1114.txt	0	4	BRCA1	NNS	*	-	-	-	-	*	-
en_1114.txt	0	5	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	6	BRCA2	NN	*	-	-	-	-	*	-
en_1114.txt	0	7	genes	NNS	*)))	-	-	-	-	*	-
en_1114.txt	0	8	are	VBP	(VP(VP*	-	-	-	-	*	-
en_1114.txt	0	9	unable	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	11	undergo	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	12	recombination	NN	(NP*))))))	-	-	-	-	*	-
en_1114.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	14	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	15	therefore	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	16	much	RB	(ADJP(ADVP*	-	-	-	-	*	-
en_1114.txt	0	17	more	RBR	*)	-	-	-	-	*	-
en_1114.txt	0	18	sensitive	JJ	*	-	-	-	-	*	-
en_1114.txt	0	19	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	20	an	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	21	increased	JJ	*	-	-	-	-	*	-
en_1114.txt	0	22	level	NN	*)	-	-	-	-	*	-
en_1114.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	24	unrepaired	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	25	single-strand	JJ	*	-	-	-	-	*	-
en_1114.txt	0	26	breaks	NNS	*)))))))	-	-	-	-	*	-
en_1114.txt	0	27	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	(9
en_1114.txt	0	1	normal	JJ	*	-	-	-	-	*	-
en_1114.txt	0	2	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	4	women	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	5	carrying	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	7	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	8	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	9	BRCA2	NN	*	-	-	-	-	*	-
en_1114.txt	0	10	mutations	NNS	*)))))	-	-	-	-	*	9)
en_1114.txt	0	11	can	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	12	still	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	13	recombine	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	14	,	,	*	-	-	-	-	*	-
en_1114.txt	0	15	because	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	16	they	PRP	(S(NP*)	-	-	-	-	*	(9)
en_1114.txt	0	17	retain	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	18	one	CD	(NP*	-	-	-	-	*	-
en_1114.txt	0	19	functional	JJ	*	-	-	-	-	*	-
en_1114.txt	0	20	allele	NN	*	-	-	-	-	*	-
en_1114.txt	0	21	—	NN	*)))))))	-	-	-	-	*	-
en_1114.txt	0	22	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	23	alternative	NN	(S(NP*)	-	-	-	-	*	-
en_1114.txt	0	24	form	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	25	—	SYM	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	26	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	27	the	DT	(NP*	-	-	-	-	*	(3
en_1114.txt	0	28	gene	NN	*)))))	-	-	-	-	*	3)
en_1114.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Only	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	those	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	2	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	3	losing	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	this	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	5	remaining	VBG	*	-	-	-	-	*	-
en_1114.txt	0	6	functional	JJ	*	-	-	-	-	*	-
en_1114.txt	0	7	allele	NN	*)	-	-	-	-	*	-
en_1114.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	9	the	DT	(NP*	-	-	-	-	*	(3
en_1114.txt	0	10	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	11	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	12	BRCA2	NNP	*	-	-	-	-	*	-
en_1114.txt	0	13	gene	NN	*)))))	-	-	-	-	*	3)
en_1114.txt	0	14	will	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	15	become	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	16	tumors	NNS	(NP*)))	-	-	-	-	*	-
en_1114.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Thus	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	only	RB	(NP*	-	-	-	-	*	-
en_1114.txt	0	3	the	DT	*	-	-	-	-	*	-
en_1114.txt	0	4	tumor	NN	*	-	-	-	-	*	-
en_1114.txt	0	5	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	6	will	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	have	VB	(VP(VP*	-	-	-	-	*	-
en_1114.txt	0	8	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	9	non-functional	JJ	*	-	-	-	-	*	-
en_1114.txt	0	10	recombination	NN	*	-	-	-	-	*	-
en_1114.txt	0	11	pathway	NN	*))	-	-	-	-	*	-
en_1114.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	13	rely	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	14	completely	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	16	PARP	NNP	(NP*))	-	-	-	-	*	(6)
en_1114.txt	0	17	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	18	repair	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	19	single-strand	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	20	breaks	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	21	before	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	22	copying	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	23	the	DT	(NP*	-	-	-	-	*	(8
en_1114.txt	0	24	DNA	NN	*))))))))))	-	-	-	-	*	8)
en_1114.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1114.txt	0	1	our	PRP$	(NP*	-	-	-	-	*	(10)
en_1114.txt	0	2	research	NN	*))	-	-	-	-	*	-
en_1114.txt	0	3	,	,	*	-	-	-	-	*	-
en_1114.txt	0	4	we	PRP	(NP*)	-	-	-	-	*	(10)
en_1114.txt	0	5	exploit	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	this	DT	(S(NP*	-	-	-	-	*	-
en_1114.txt	0	7	requirement	NN	*)	-	-	-	-	*	-
en_1114.txt	0	8	to	TO	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	specifically	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	10	target	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	12	BRCA1	JJ	(UCP*	-	-	-	-	*	-
en_1114.txt	0	13	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	14	BRCA2-defective	NN	*)	-	-	-	-	*	-
en_1114.txt	0	15	cancer	NN	*	-	-	-	-	*	-
en_1114.txt	0	16	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	18	inhibitors	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	20	PARP	NNP	(NP*)))))))))	-	-	-	-	*	(6)
en_1114.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	This	DT	(TOP(S(S(NP*	-	-	-	-	*	(5
en_1114.txt	0	1	treatment	NN	*)	-	-	-	-	*	5)
en_1114.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	unlikely	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	4	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	5	cause	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	many	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	7	side	NN	*	-	-	-	-	*	-
en_1114.txt	0	8	effects	NNS	*)))))))	-	-	-	-	*	-
en_1114.txt	0	9	;	:	*	-	-	-	-	*	-
en_1114.txt	0	10	prolonged	JJ	(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	11	treatments	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	12	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	13	PARP	JJ	(NP*	-	-	-	-	*	(11
en_1114.txt	0	14	inhibitors	NNS	*)))	-	-	-	-	*	11)
en_1114.txt	0	15	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	16	well	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	17	tolerated	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	18	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	19	mice	NNS	(NP*)))))	-	-	-	-	*	-
en_1114.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_1114.txt	0	1	have	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	shown	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_1114.txt	0	4	PARP	NNP	(S(NP*	-	-	-	-	*	(11
en_1114.txt	0	5	inhibitors	NNS	*)	-	-	-	-	*	11)
en_1114.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	effective	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	8	at	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	9	killing	VBG	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	10	BRCA2-defective	NNP	(NP*	-	-	-	-	*	-
en_1114.txt	0	11	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	12	cancer	NN	*	-	-	-	-	*	-
en_1114.txt	0	13	cells	NNS	*))))))))	-	-	-	-	*	-
en_1114.txt	0	14	,	,	*	-	-	-	-	*	-
en_1114.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	16	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	17	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	18	tumors	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	19	they	PRP	(SBAR(S(NP*)	-	-	-	-	*	(11)
en_1114.txt	0	20	cause	VBP	(VP*))))	-	-	-	-	*	-
en_1114.txt	0	21	can	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	22	fully	RB	(VP(VP(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	23	regress	VB	*)	-	-	-	-	*	-
en_1114.txt	0	24	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	25	disappear	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	26	following	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	27	treatment	NN	*)	-	-	-	-	*	-
en_1114.txt	0	28	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	29	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	30	PARP	NNP	*	-	-	-	-	*	-
en_1114.txt	0	31	inhibitor	NN	*))))))))))	-	-	-	-	*	-
en_1114.txt	0	32	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1114.txt	0	1	next	JJ	*	-	-	-	-	*	-
en_1114.txt	0	2	step	NN	*)	-	-	-	-	*	-
en_1114.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	5	investigate	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	how	WRB	(SBAR(WHADJP*	-	-	-	-	*	-
en_1114.txt	0	7	efficient	JJ	*)	-	-	-	-	*	-
en_1114.txt	0	8	this	DT	(S(NP*	-	-	-	-	*	(5
en_1114.txt	0	9	treatment	NN	*)	-	-	-	-	*	5)
en_1114.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	12	human	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	13	patients	NNS	*)))))))))	-	-	-	-	*	-
en_1114.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_1114.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	now	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	3	initiating	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	clinical	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	5	trials	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	7	determine	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	how	WRB	(SBAR(WHADJP*	-	-	-	-	*	-
en_1114.txt	0	9	efficient	JJ	*)	-	-	-	-	*	-
en_1114.txt	0	10	these	DT	(S(NP*	-	-	-	-	*	(11
en_1114.txt	0	11	PARP	JJ	*	-	-	-	-	*	-
en_1114.txt	0	12	inhibitors	NNS	*)	-	-	-	-	*	11)
en_1114.txt	0	13	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	16	treatment	NN	*)	-	-	-	-	*	-
en_1114.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	18	metastasized	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	19	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	20	tumors	NNS	*))))))))))))	-	-	-	-	*	-
en_1114.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1114.txt	0	1	caution	NN	(NP*)	-	-	-	-	*	-
en_1114.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	4	order	NN	(NP*)))	-	-	-	-	*	-
en_1114.txt	0	5	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	BRCA1	NNS	(TOP(S(NP*	-	-	-	-	*	-
en_1114.txt	0	1	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	2	BRCA2-defective	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	3	tumors	NNS	*))	-	-	-	-	*	-
en_1114.txt	0	4	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	5	characterized	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	6	by	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	7	a	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	8	high	JJ	*	-	-	-	-	*	-
en_1114.txt	0	9	degree	NN	*)	-	-	-	-	*	-
en_1114.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	11	genetic	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	12	instability	NN	*))))))	-	-	-	-	*	-
en_1114.txt	0	13	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	-
en_1114.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	possible	JJ	(ADJP*)	-	-	-	-	*	-
en_1114.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	4	highly	RB	(S(NP(ADJP*	-	-	-	-	*	-
en_1114.txt	0	5	metastasized	VBN	*)	-	-	-	-	*	-
en_1114.txt	0	6	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	7	tumors	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	8	might	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	have	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	10	acquired	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	11	additional	JJ	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	12	genetic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	13	changes	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	14	causing	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	15	resistance	NN	(NP*)	-	-	-	-	*	-
en_1114.txt	0	16	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	17	treatment	NN	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	18	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	19	PARP	NNP	(NP*	-	-	-	-	*	(11
en_1114.txt	0	20	inhibitors	NNS	*))))))))))))	-	-	-	-	*	11)
en_1114.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Therefore	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	we	PRP	(NP*)	-	-	-	-	*	(10)
en_1114.txt	0	3	suggest	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	5	PARP	NNP	(S(NP*	-	-	-	-	*	(11
en_1114.txt	0	6	inhibitors	NNS	*)	-	-	-	-	*	11)
en_1114.txt	0	7	might	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	be	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	more	RBR	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	10	useful	JJ	*	-	-	-	-	*	-
en_1114.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	13	prophylactic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	14	treatment	NN	*)	-	-	-	-	*	-
en_1114.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	16	women	NNS	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	17	carrying	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	18	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	19	gene	NN	*)	-	-	-	-	*	-
en_1114.txt	0	20	responsible	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	22	this	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	23	form	NN	*)	-	-	-	-	*	-
en_1114.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	25	inherited	VBN	(NP*	-	-	-	-	*	-
en_1114.txt	0	26	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	27	cancer	NN	*)))))))))))))))))	-	-	-	-	*	-
en_1114.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	The	DT	(TOP(S(S(NP*	-	-	-	-	*	-
en_1114.txt	0	1	reason	NN	*)	-	-	-	-	*	-
en_1114.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	simple	JJ	(ADJP*)))	-	-	-	-	*	-
en_1114.txt	0	4	:	:	*	-	-	-	-	*	-
en_1114.txt	0	5	cells	NNS	(S(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	6	that	WDT	(SBAR(SBAR(WHNP*)	-	-	-	-	*	-
en_1114.txt	0	7	have	VBP	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	8	recently	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	9	lost	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	11	functional	JJ	*	-	-	-	-	*	-
en_1114.txt	0	12	BRCA1	NNP	*	-	-	-	-	*	-
en_1114.txt	0	13	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	14	BRCA2	NNP	*	-	-	-	-	*	-
en_1114.txt	0	15	allele	NN	*)))))	-	-	-	-	*	-
en_1114.txt	0	16	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	17	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1114.txt	0	18	will	MD	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	19	later	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	20	grow	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	21	into	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	22	tumors	NNS	(NP*))))))))	-	-	-	-	*	-
en_1114.txt	0	23	will	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	24	also	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	25	be	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	26	unable	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	27	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	28	undergo	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	29	recombination	NN	(NP*))))))))	-	-	-	-	*	-
en_1114.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1114.txt	0	1	means	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	3	early	JJ	(S(NP*	-	-	-	-	*	-
en_1114.txt	0	4	cancerous	JJ	*	-	-	-	-	*	-
en_1114.txt	0	5	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	6	should	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	be	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	sensitive	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	9	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	10	PARP	JJ	(NP*	-	-	-	-	*	(12
en_1114.txt	0	11	inhibitors	NNS	*))))))))	-	-	-	-	*	12)
en_1114.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	However	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	unlike	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	3	fully	RB	(NP*	-	-	-	-	*	-
en_1114.txt	0	4	developed	JJ	*	-	-	-	-	*	-
en_1114.txt	0	5	tumors	NNS	*))	-	-	-	-	*	-
en_1114.txt	0	6	,	,	*	-	-	-	-	*	-
en_1114.txt	0	7	they	PRP	(NP*)	-	-	-	-	*	(12)
en_1114.txt	0	8	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	9	not	RB	*	-	-	-	-	*	-
en_1114.txt	0	10	likely	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	11	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	12	have	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	acquired	VBN	(VP(VP*	-	-	-	-	*	-
en_1114.txt	0	14	many	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	15	genetic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	16	changes	NNS	*))	-	-	-	-	*	-
en_1114.txt	0	17	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	18	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	19	therefore	RB	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	20	unlikely	JJ	*	-	-	-	-	*	-
en_1114.txt	0	21	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	22	have	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	23	gained	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	24	resistance	NN	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	25	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	26	PARP	NNP	(NP*	-	-	-	-	*	(12
en_1114.txt	0	27	inhibitors	NNS	*)))))))))))))))	-	-	-	-	*	12)
en_1114.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Treating	VBG	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	1	women	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	2	carrying	VBG	(VP*	-	-	-	-	*	-
en_1114.txt	0	3	BRCA1	NN	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	4	or	CC	*	-	-	-	-	*	-
en_1114.txt	0	5	BRCA2	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	6	mutations	NNS	*))	-	-	-	-	*	-
en_1114.txt	0	7	with	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	8	PARP	NNP	(NP*	-	-	-	-	*	(12
en_1114.txt	0	9	inhibitors	NNS	*))	-	-	-	-	*	12)
en_1114.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	11	kill	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	12	cancer	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	13	cells	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	14	before	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	15	they	PRP	(S(NP*)	-	-	-	-	*	(12)
en_1114.txt	0	16	grow	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	17	into	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	18	tumors	NNS	(NP*)))))))))))	-	-	-	-	*	-
en_1114.txt	0	19	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	20	a	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	21	new	JJ	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	22	and	CC	*	-	-	-	-	*	-
en_1114.txt	0	23	hopeful	JJ	*)	-	-	-	-	*	-
en_1114.txt	0	24	concept	NN	*)	-	-	-	-	*	-
en_1114.txt	0	25	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	26	cancer	NN	(NP*	-	-	-	-	*	-
en_1114.txt	0	27	prevention	NN	*))))	-	-	-	-	*	-
en_1114.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	However	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	3	usefulness	NN	*)	-	-	-	-	*	-
en_1114.txt	0	4	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	5	this	DT	(NP*	-	-	-	-	*	(5
en_1114.txt	0	6	treatment	NN	*)))	-	-	-	-	*	5)
en_1114.txt	0	7	relies	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	8	on	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	9	the	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	10	fact	NN	*	-	-	-	-	*	-
en_1114.txt	0	11	that	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	12	PARP1	NN	(S(NP*	-	-	-	-	*	-
en_1114.txt	0	13	inhibitors	NNS	*)	-	-	-	-	*	-
en_1114.txt	0	14	are	VBP	(VP*	-	-	-	-	*	-
en_1114.txt	0	15	completely	RB	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	16	non-toxic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	17	to	TO	(PP*	-	-	-	-	*	-
en_1114.txt	0	18	humans	NNS	(NP*)))))))))	-	-	-	-	*	-
en_1114.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(5)
en_1114.txt	0	1	will	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	2	also	RB	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	3	take	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	4	longer	RBR	(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	6	validate	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	7	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	8	PARP	JJ	*	-	-	-	-	*	-
en_1114.txt	0	9	inhibitor	NN	*)	-	-	-	-	*	-
en_1114.txt	0	10	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	11	use	NN	(NP(NP*)	-	-	-	-	*	-
en_1114.txt	0	12	as	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	13	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	14	prophylactic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	15	treatment	NN	*)))))))	-	-	-	-	*	-
en_1114.txt	0	16	,	,	*	-	-	-	-	*	-
en_1114.txt	0	17	because	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	18	the	DT	(S(NP*	-	-	-	-	*	-
en_1114.txt	0	19	treatment	NN	*	-	-	-	-	*	-
en_1114.txt	0	20	cannot	NN	*)	-	-	-	-	*	-
en_1114.txt	0	21	be	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	22	proven	VBN	(VP*	-	-	-	-	*	-
en_1114.txt	0	23	effective	JJ	(ADJP*)	-	-	-	-	*	-
en_1114.txt	0	24	in	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	25	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	26	short	JJ	*	-	-	-	-	*	-
en_1114.txt	0	27	time	NN	*))))))))	-	-	-	-	*	-
en_1114.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1114.txt	0	0	Thus	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1114.txt	0	1	,	,	*	-	-	-	-	*	-
en_1114.txt	0	2	while	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	3	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	4	use	NN	*)	-	-	-	-	*	-
en_1114.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	6	PARP	NNP	(NP*	-	-	-	-	*	-
en_1114.txt	0	7	inhibitors	NNS	*	-	-	-	-	*	-
en_1114.txt	0	8	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	9	treat	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	10	established	JJ	(NP*	-	-	-	-	*	-
en_1114.txt	0	11	tumors	NNS	*)))))))	-	-	-	-	*	-
en_1114.txt	0	12	may	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	13	be	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	14	feasible	JJ	(ADJP*)	-	-	-	-	*	-
en_1114.txt	0	15	within	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	16	a	DT	(NP*	-	-	-	-	*	-
en_1114.txt	0	17	few	JJ	*	-	-	-	-	*	-
en_1114.txt	0	18	years	NNS	*))))))	-	-	-	-	*	-
en_1114.txt	0	19	,	,	*	-	-	-	-	*	-
en_1114.txt	0	20	we	PRP	(NP*)	-	-	-	-	*	-
en_1114.txt	0	21	could	MD	(VP*	-	-	-	-	*	-
en_1114.txt	0	22	have	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	23	to	TO	(S(VP*	-	-	-	-	*	-
en_1114.txt	0	24	wait	VB	(VP*	-	-	-	-	*	-
en_1114.txt	0	25	at	IN	(NP(QP*	-	-	-	-	*	-
en_1114.txt	0	26	least	JJS	*	-	-	-	-	*	-
en_1114.txt	0	27	a	DT	*)	-	-	-	-	*	-
en_1114.txt	0	28	decade	NN	*)	-	-	-	-	*	-
en_1114.txt	0	29	before	IN	(SBAR*	-	-	-	-	*	-
en_1114.txt	0	30	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_1114.txt	0	31	prophylactic	JJ	*	-	-	-	-	*	-
en_1114.txt	0	32	treatment	NN	*)	-	-	-	-	*	-
en_1114.txt	0	33	for	IN	(PP*	-	-	-	-	*	-
en_1114.txt	0	34	inherited	VBN	(NP*	-	-	-	-	*	-
en_1114.txt	0	35	breast	NN	*	-	-	-	-	*	-
en_1114.txt	0	36	cancer	NN	*)))	-	-	-	-	*	-
en_1114.txt	0	37	is	VBZ	(VP*	-	-	-	-	*	-
en_1114.txt	0	38	widely	RB	(ADJP*	-	-	-	-	*	-
en_1114.txt	0	39	available	JJ	*)))))))))	-	-	-	-	*	-
en_1114.txt	0	40	.	.	*))	-	-	-	-	*	-

#end document
